Ashland is planning to sell its Nutraceuticals business segment and invest in other core segments as its consolidates its portfolio.
© 2023 Delaware Business Times
Flash Sale! Subscribe to Delaware Business Times and save 50%.
Limited time offer. New subscribers only.
SUMMER FLASH SALE!
Subscribe to Delaware Business Times and save 50%